Everything depends on one single decision - is admin/moderator/valuepickr in its totality responsible for content ? If you say yes then you will have to vet new threads,read thro' each posts,confirm for balanced views etc etc . Its not practical in the long run.If you say no then this can be another Money control where over medium term brand will surely get diluted.What i suggested as a one time rank is a via media absolving too much effort by admin trying to counter motivated posters but at the same time having a control over the thread because the "rank " that they give will override a 1000 words and anyone who reads the thread will ask " why valuepickr seniors are giving this stock a ranking of 5 and calling it a suspect idea " ?

Q2FY16 Results declared
BSE Results link

Revenue Growth 13%
EBITDA Growth 25% (Margin 21.61% vs 19.44%)
PBT Growth 31%
PAT Growth 30% (excluding exceptional item)

• Exceptional loss of 2.42cr reported, dragging reported PAT down to 20cr

Overall looks good set of numbers, considering that we are not expecting any fireworks until US FDA approval and revenue growth thereafter.

Mr. Bhutada had already clarified after Q4FY15 results that all the ongoing initiatives will drive revenue growth by 2016 end or 2017. Until then 5-10% growth guidance was provided. They have done better than the near term guidance at least.

However, brokers have a different set of expectations.(FY16 growth: IndiaNivesh 24.5%, Karvy 23.5%)

Hi Sunil,
Now its working properly. I thought, As I have commented on thread after few months and brought it on surface, due to overload it went off. Sorry if its so. Thanks a lot. Receiving email now.

Lot of pharma companies have started paying attention to OTC brands. This adds another revenue stream to their portfolio of products which is out price control regime and not affected by US FDA/UK MHRA inspection scares. This also helps them to migrate from pure "pharma" to quasi FMCG-pharma company. Piramal has been making conscious effort by acquiring brands like Saridon, Lacto Calamine, I-pill etc. Recent acquisition seems to in line with their OTC strategy.

Please see the article in Outlook Business about OTC brands

http://www.outlookbusiness.com/strategy/feature/if-youve-got-it-flaunt-it-1970

Disc : invested

Hi Sunil,

I am not getting alerts from couple of weeks. I checked in SPAM folder also but didn't find the alerts. It is very helpful for to track BSE alerts and I was using it from quite sometime. Can you please tell me anything wrong.

Thanks
Chetan